Eikon Therapeutics
Eikon Therapeutics advances breakthrough therapeutics by integrating engineering and science, utilizing proprietary single-molecule tracking technology to discover and develop new medicines. The company focuses on oncology, immunology, and neuroscience, leveraging AI and Nobel Prize-winning microscopy tools to address serious illnesses with unmet medical needs.
Services
Eikon Therapeutics aims to advance breakthrough therapeutics by integrating engineering and science. The company discovers and develops new medicines, focusing on quantifying the behavior of biological systems. Eikon leverages high-performance tools, invents new instruments, and integrates AI capabilities and advanced automation to enhance its research and development efforts.
Single-Molecule Tracking (SMT) Platform
Eikon Therapeutics employs a proprietary single-molecule tracking (SMT) platform, which visualizes hundreds of thousands of protein motion events in living cells in less than a second. This technology allows for precise measurement of the dynamic behavior of individual protein molecules on a massive scale. By using Nobel Prize-winning super-resolution fluorescence microscopy tools, the company visualizes the dynamics of macromolecules within live cells, providing unique insights.
Therapeutic Areas
Eikon Therapeutics is advancing numerous preclinical and clinical programs across a broad range of therapeutic areas, including oncology, immunology, and neuroscience. The company’s growing therapeutic pipeline shows promise for addressing serious illnesses with severely unmet medical needs. Notably, Eikon's clinical programs have evidenced activity in the treatment of solid tumors.
Locations
Eikon Therapeutics operates from several locations: 3929 Point Eden Way, Hayward, CA 94545; 450 East 29th St @ 1st Ave, 15th Floor, New York, NY 10016; 24590 Clawiter Road, Hayward, CA 94545; and 3 2nd St, 4th Floor, Jersey City, NJ 07302. These sites support the company's state-of-the-art research and development initiatives.